Regeneron Q3 Profit Rises to $1.95 Billion as Revenue Jumps 36.3%

Regeneron Pharmaceuticals Inc. (REGN) reported third-quarter earnings of $1.949 billion, or $18.45 per share, up from $1.460 billion, or $13.62 per share, in the prior-year period. Excluding items, the company posted adjusted earnings of $2.150 billion, or $20.07 per share. Revenue for the quarter rose 36.3% to $5.116 billion from $3.754 billion a year earlier.